The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, X.-Z.
Right arrow Articles by Dong, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, X.-Z.
Right arrow Articles by Dong, C.
The Journal of Immunology, 2006, 176: 7394-7401.
Copyright © 2006 by The American Association of Immunologists

Opposing Effects of ICOS on Graft-versus-Host Disease Mediated by CD4 and CD8 T Cells1

Xue-Zhong Yu2,*,{dagger}, Yaming Liang*, Roza I. Nurieva{ddagger}, Fei Guo*, Claudio Anasetti*,{dagger} and Chen Dong{ddagger}

* Immunology and Blood and Marrow Transplantation Programs, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612; {dagger} Department of Interdisciplinary Oncology, University of South Florida, Tampa, FL 33612; and {ddagger} Department of Immunology, MD Anderson Cancer Center, Houston, TX 77030

ICOS, a CD28 family member expressed on activated CD4+ and CD8+ T cells, plays important roles in T cell activation and effector function. Here we studied the role of ICOS in graft-vs-host disease (GVHD) mediated by CD4+ or CD8+ T cells in allogeneic bone marrow transplantation. In comparison of wild-type and ICOS-deficient T cells, we found that recipients of ICOS–/– CD4+ T cells exhibited significantly less GVHD morbidity and delayed mortality. ICOS–/– CD4+ T cells had no defect in expansion, but expressed significantly less Fas ligand and produced significantly lower levels of IFN-{gamma} and TNF-{alpha}. Thus, ICOS–/– CD4+ T cells were impaired in effector functions that lead to GVHD. In contrast, recipients of ICOS–/– CD8+ T cells exhibited significantly enhanced GVHD morbidity and accelerated mortality. In the absence of ICOS signaling, either using ICOS-deficient donors or ICOS ligand-deficient recipients, the levels of expansion and Tc1 cytokine production of CD8+ T cells were significantly increased. The level of expansion was inversely correlated with the level of apoptosis, suggesting that increased ability of ICOS–/– CD8+ T cells to induce GVHD resulted from the enhanced survival and expansion of those cells. Our findings indicate that ICOS has paradoxical effects on the regulation of alloreactive CD4+ and CD8+ T cells in GVHD.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Hawiger, E. Tran, W. Du, C. J. Booth, L. Wen, C. Dong, and R. A. Flavell
ICOS Mediates the Development of Insulin-Dependent Diabetes Mellitus in Nonobese Diabetic Mice
J. Immunol., March 1, 2008; 180(5): 3140 - 3147.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Liang, C. Liu, J. Y. Djeu, B. Zhong, T. Peters, K. Scharffetter-Kochanek, C. Anasetti, and X.-Z. Yu
2 integrins separate graft-versus-host disease and graft-versus-leukemia effects
Blood, January 15, 2008; 111(2): 954 - 962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.